doxepin has been researched along with Obesity in 2 studies
Doxepin: A dibenzoxepin tricyclic compound. It displays a range of pharmacological actions including maintaining adrenergic innervation. Its mechanism of action is not fully understood, but it appears to block reuptake of monoaminergic neurotransmitters into presynaptic terminals. It also possesses anticholinergic activity and modulates antagonism of histamine H(1)- and H(2)-receptors.
doxepin : A dibenzooxepine that is 6,11-dihydrodibenzo[b,e]oxepine substituted by a 3-(dimethylamino)propylidene group at position 11. It is used as an antidepressant drug.
Obesity: A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
Excerpt | Relevance | Reference |
---|---|---|
"Doxepin was used as the anti-depressant in a double blind procedure." | 1.27 | Emotional problems during weight reduction: advantages of a combined behavior therapy and antidepressive drug therapy for obesity. ( Cayiroglu, S; Nutzinger, DO; Sachs, G; Zapotoczky, HG, 1985) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Nutzinger, DO | 2 |
Cayiroglu, S | 2 |
Sachs, G | 2 |
Stellamor, M | 1 |
Zapotoczky, HG | 2 |
2 other studies available for doxepin and Obesity
Article | Year |
---|---|
[A behaviorally oriented group therapy concept for the treatment of a risk group of obese patients].
Topics: Adolescent; Adult; Behavior Therapy; Combined Modality Therapy; Double-Blind Method; Doxepin; Female | 1983 |
Emotional problems during weight reduction: advantages of a combined behavior therapy and antidepressive drug therapy for obesity.
Topics: Adult; Behavior Therapy; Combined Modality Therapy; Depression; Diet, Reducing; Doxepin; Female; Hum | 1985 |